Evidence map›Paper›PMID 26511985›Full record

ArticleGlycoconjugate journal2016

Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines : HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.

Hiromi Ito, Hiroyuki Kaji, Akira Togayachi, Parastoo Azadi, Mayumi Ishihara, Rudolf Geyer, Christina Galuska, Hildegard Geyer, Kazuaki Kakehi, Mitsuhiro Kinoshita and 21 more

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Glycoconjugate journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Analysis of Lacto/Neolacto-Series Glycolipids and Gangliosides.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
  3. Article
  4. The Hitchhiker's guide to glycoproteomics.Biochemical Society transactions · 2021
    Review
  5. Article
  6. Review
  7. High-throughput SerumMolecular & cellular proteomics : MCP · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 7 countries.

Hiromi Ito *National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568, Japan.
Hiroyuki Kaji *National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568, Japan.
Akira TogayachiNational Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568, Japan.
Parastoo AzadiComplex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens 30602, USA.
Mayumi IshiharaComplex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens 30602, USA.
Rudolf GeyerInstitute of Biochemistry, Faculty of Medicine, University of Giessen, Giessen D-35392, Germany.
Christina GaluskaInstitute of Biochemistry, Faculty of Medicine, University of Giessen, Giessen D-35392, Germany.
Hildegard GeyerInstitute of Biochemistry, Faculty of Medicine, University of Giessen, Giessen D-35392, Germany.
Kazuaki KakehiDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Kinki University, Osaka 577-8502, Japan.
Mitsuhiro KinoshitaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Kinki University, Osaka 577-8502, Japan.
Niclas G KarlssonDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden.
Chunsheng JinDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 40530, Sweden.
Koichi KatoGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Hirokazu YagiGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Sachiko KondoGraduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Nana KawasakiDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tokyo 158-8501, Japan.
Noritaka HashiiDivision of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tokyo 158-8501, Japan.
Daniel KolarichDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam D-14424, Germany.
Kathrin StavenhagenDepartment of Biomolecular Systems, Max Planck Institute of Colloids and Interfaces, Potsdam D-14424, Germany.
Nicolle H PackerDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney 2109, Australia.
Morten Thaysen-AndersenDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney 2109, Australia.
Miyako NakanoDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney 2109, Australia.
Naoyuki TaniguchiDisease Glycomics Team, RIKEN, Saitama 351-0198, Japan.
Ayako KurimotoDisease Glycomics Team, RIKEN, Saitama 351-0198, Japan.
Yoshinao WadaOsaka Medical Center and Research Institute for Maternal and Child Health, Osaka 594-1101, Japan.
Michiko TajiriOsaka Medical Center and Research Institute for Maternal and Child Health, Osaka 594-1101, Japan.
Pengyuan YangDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, China.
Weiqian CaoDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, China.
Hong LiDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai 200433, China.
Pauline M RuddNational Institute for Bioprocessing Research and Training (NIBRT), Dublin, Ireland.
Hisashi NarimatsuNational Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8568, Japan.
National Institute of Advanced Industrial Science and Technology · JPFudan University · CNMacquarie University · AUNagoya City University · JPUniversity of Giessen · DEKindai University · JPMax Planck Institute of Colloids and Interfaces · DENational Institute of Health Sciences · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPRIKEN · JPUniversity of Georgia · USUniversity of Gothenburg · SENational Institute for Bioprocessing Research and Training · IE

Funding

TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)P41GM103490 · NIGMS · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2012 to 2018
$13.7M
NIGMS NIH HHS P41 GM103490
6 · The paper itself

Abstract

The Human Disease Glycomics/Proteome Initiative (HGPI) is an activity in the Human Proteome Organization (HUPO) supported by leading researchers from international institutes and aims at development of disease-related glycomics/glycoproteomics analysis techniques. Since 2004, the initiative has conducted three pilot studies. The first two were N- and O-glycan analyses of purified transferrin and immunoglobulin-G and assessed the most appropriate analytical approach employed at the time. This paper describes the third study, which was conducted to compare different approaches for quantitation of N- and O-linked glycans attached to proteins in crude biological samples. The preliminary analysis on cell pellets resulted in wildly varied glycan profiles, which was probably the consequence of variations in the pre-processing sample preparation methodologies. However, the reproducibility of the data was not improved dramatically in the subsequent analysis on cell lysate fractions prepared in a specified method by one lab. The study demonstrated the difficulty of carrying out a complete analysis of the glycome in crude samples by any single technology and the importance of rigorous optimization of the course of analysis from preprocessing to data interpretation. It suggests that another collaborative study employing the latest technologies in this rapidly evolving field will help to realize the requirements of carrying out the large-scale analysis of glycoproteins in complex cell samples.

Indexed as

BiomarkersCell Line, TumorChromatography, High Pressure LiquidGlycomicsGlycoproteinsHumansMass SpectrometryMolecular Diagnostic TechniquesPolysaccharidesProteomicsReproducibility of ResultsBiomarkersGlycoproteinsPolysaccharidesGlycoproteomicsHuman disease glycomics/proteome initiative (HGPI)Human proteome organization (HUPO)

Identifiers

PMID26511985
PMCPMC4848167
OpenAlexW2405664412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.